Q48334688 | A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. |
Q89543466 | DNA methylation alterations as therapeutic prospects in thyroid cancer |
Q38680431 | Epigenetic alternations and cancer chemotherapy response |
Q97524093 | LINC01619 promotes non-small cell lung cancer development via regulating PAX6 by suppressing microRNA-129-5p |
Q36417380 | Parsing interindividual drug variability: an emerging role for systems pharmacology |
Q38776883 | Pharmacogenetics of cancer therapy: breakthroughs from beyond? |
Search more.